Discover 651 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 651
Active & Responsive
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
for
Relapsing Multiple Sclerosis (RMS)
Location: Milwaukee WI, Greenfield WI, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06869785
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Milwaukee WI, Chicago IL, Buffalo NY, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780137
Phase1, Phase2, Recruiting
Active & Responsive
Computer-guided Action Planning to Support Physical Activity (CAPPA) for Employees with Chronic Knee Symptoms
for
Osteoarthritis of Knee, Knee Pain Chronic
Location: Milwaukee WI
Sponsor: Marquette University
Sex: All
Age: 18+
Code: NCT06734052
Recruiting
Active & Responsive
A Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
for
Mantle Cell Lymphoma (MCL)
Location: Milwaukee WI
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06788652
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis